Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01$4.86/sh+2,650$12,879→ 2,650 totalExercise: $7.92From: 2022-04-01Exp: 2032-04-01→ Common Stock (2,650 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.